Bradford D. Dahms, Chief Financial Officer at Theseus Pharmaceuticals, Inc. (THRX), bought 1,970 shares at $10.15 ($20K) on 2021-12-21, disclosed to the SEC on 2021-12-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.